Journal of Medical Virology
Volume 88, Issue 6, 2016, Pages 1044-1050
Epidemiology of hepatitis C virus infection in a large Israeli health maintenance organization (Article)
Weil C.* ,
Nwankwo C. ,
Friedman M. ,
Kenet G. ,
Chodick G. ,
Shalev V.
-
a
Epidemiology and Database Research, Maccabi Healthcare Services, Tel Aviv, Israel
-
b
Global Health Outcomes, Merck and Co., Inc., Kenilworth, NJ, United States
-
c
Epidemiology and Database Research, Maccabi Healthcare Services, Tel Aviv, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
-
d
Epidemiology and Database Research, Maccabi Healthcare Services, Tel Aviv, Israel
-
e
Epidemiology and Database Research, Maccabi Healthcare Services, Tel Aviv, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
-
f
Epidemiology and Database Research, Maccabi Healthcare Services, Tel Aviv, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Abstract
Hepatitis C affects an estimated 130 million people worldwide and is a major cause of chronic liver disease. This retrospective database study aims to describe the epidemiology of HCV-infected patients in Maccabi Healthcare Services, a 2-million-member health maintenance organization in Israel. HCV was identified by cross-linking diagnoses, laboratory data, and dispensed HCV treatment (1993-2013). The point-prevalence of HCV in 2012 and annual incidence of newly-diagnosed HCV during 2003-2012 (index period) were calculated. The age-adjusted prevalence of HCV was 5.19/1,000 population (n=10,648). The highest prevalence was found among males and in patients aged 35-54 years. Two thirds of HCV-infected patients were immigrants from the former Soviet Union (FSU). HCV genotype 1 was predominant (67%). A total of 6,150 patients were newly diagnosed with HCV infection during the index period. The age-standardized rate of newly-diagnosed HCV declined from over 50/100,000 (2003) to 15/100,000 (2012). This rate was highest in males from the FSU, particularly for birth cohorts in 1950-70. The study results suggest that the reported incidence of HCV infection in Israel is declining, while prevalence is particularly high among FSU immigrants and genotype 1 is predominant. As the HCV treatment landscape evolves, these estimates can inform future studies and health technology assessments. © 2015 Wiley Periodicals, Inc.
Author Keywords
Index Keywords
Link
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84947755517&doi=10.1002%2fjmv.24426&partnerID=40&md5=b156621984751e1fcf0321faef53cc99
DOI: 10.1002/jmv.24426
ISSN: 01466615
Cited by: 6
Original Language: English